Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

SIMPLE SUMMARY: KRAS G12C mutations are important oncogenic mutations in lung cancer that can now be targeted by allosteric small molecule inhibitors. We assessed the imaging features and patterns of metastases in these lung cancers compared to other mutated lung cancers. We found that KRAS G12C NSC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Wu, Markus Y., Zhang, Eric W., Strickland, Matthew R., Mendoza, Dexter P., Lipkin, Lev, Lennerz, Jochen K., Gainor, Justin F., Heist, Rebecca S., Digumarthy, Subba R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8304953/
https://ncbi.nlm.nih.gov/pubmed/34298783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143572
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak